While the present study did not directly assess endothelial function, our findings suggest that the pharmacological targeting of adipose lipolysis, specifically through the inhibition of ATGL, may be a promising avenue to restoring endothelial function in obesity by preventing VAT-induced impairment of endothelial Kir2.1. Here, KCNJ2 is linked to obesity disorder.